Clinical Trial Update: Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors

View source ↗

Summary

This clinical trial aims to identify specific biomarkers of immune-mediated hepatitis that occurs secondary to immune checkpoint inhibitors. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune-mediated Hepatitis

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Immune-mediated Hepatitis | Status: RECRUITING